Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;6(3):e233068.
doi: 10.1001/jamanetworkopen.2023.3068.

Incidence of Retinal Artery Occlusion and Related Mortality in Korea, 2005 to 2018

Affiliations

Incidence of Retinal Artery Occlusion and Related Mortality in Korea, 2005 to 2018

Daniel Duck-Jin Hwang et al. JAMA Netw Open. .

Abstract

Importance: It remains unclear whether comorbidities in patients with retinal artery occlusion (RAO), a rare retinal vascular disorder, differ by subtype and whether mortality is higher.

Objective: To examine the nationwide incidence of clinically diagnosed, nonarteritic RAO, causes of death, and mortality rate in patients with RAO compared with that in the general population in Korea.

Design, setting, and participants: This retrospective, population-based cohort study examined National Health Insurance Service claims data from 2002 to 2018. The population of South Korea was 49 705 663, according to the 2015 census. Data were analyzed from February 9, 2021, to July 30, 2022.

Main outcomes and measures: The nationwide incidence of any RAO, including central RAO (CRAO; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] code, H34.1) and noncentral RAO (other RAO; ICD-10 code, H34.2) was estimated using National Health Insurance Service claims data from 2002 to 2018, with 2002 to 2004 as the washout period. Furthermore, the causes of death were evaluated and the standardized mortality ratio was estimated. The primary outcomes were the incidence of RAO per 100 000 person-years and the standardized mortality ratio (SMR).

Results: A total of 51 326 patients with RAO were identified (28 857 [56.2%] men; mean [SD] age at index date: 63.6 [14.1] years). The nationwide incidence of any RAO was 7.38 (95% CI, 7.32-7.44) per 100 000 person-years. The incidence rate of noncentral RAO was 5.12 (95% CI, 5.07-5.18), more than twice that of CRAO (2.25 [95% CI, 2.22-2.29]). Mortality was higher in patients with any RAO than in the general population (SMR, 7.33 [95% CI, 7.15-7.50]). The SMR for CRAO (9.95 [95% CI, 9.61-10.29]) and for noncentral RAO (5.97 [95% CI, 5.78-6.16]) showed a tendency toward a gradual decrease with increasing age. The top 3 causes of death in patients with RAO were diseases of the circulatory system (28.8%), neoplasms (25.1%), and diseases of the respiratory system (10.2%).

Conclusions and relevance: This cohort study found that the incidence rate of noncentral RAO was higher than that of CRAO, whereas SMR was higher for CRAO than noncentral RAO. Patients with RAO show higher mortality than the general population, with circulatory system disease as the leading cause of death. These findings suggest that it is necessary to investigate the risk of cardiovascular or cerebrovascular disease in patients newly diagnosed with RAO.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Rim reported receiving stock from Mediwhale Inc outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Incidence rates of RAO, CRAO, and Noncentral RAO
A, Incidence rates of RAO, CRAO, and noncentral RAO in the Korean population from 2005 to 2018 (per 100 000 person-years). B, Incidence rate of CRAO by sex in the Korean population for the same period (per 100 000 person-years). C, Incidence rate of noncentral RAO by sex in the Korean population for the same period (per 100 000 person-years). CRAO indicates central retinal artery occlusion; RAO, retinal artery occlusion.
Figure 2.
Figure 2.. Standardized Mortality Ratios (SMRs) of RAO in Korea From 2005 to 2018
The SMR peaked in the teens and 20s, and gradually decreased thereafter for both men and women. The SMR of central retinal artery occlusion (CRAO) tended to be higher than that of noncentral RAO.
Figure 3.
Figure 3.. Top 3 Causes of Death Among Patients With Retinal Artery Occlusion (RAO) (2005-2018) and the General Population (2015) in Korea
Among patients with RAO, diseases of the circulatory system were the most common cause of death, followed by neoplasms and diseases of the respiratory system. Among patients with RAO aged less than 50 years of age, neoplasms accounted for the largest proportion of deaths, followed by diseases of the circulatory system and external causes of morbidity. In contrast, in the general population, neoplasms were the most common cause of death, followed by diseases of the circulatory system and external causes of morbidity. In the general population aged less than 50 years, external causes of morbidity was the most common cause of death, followed by neoplasms and diseases of the circulatory system.

Comment in

References

    1. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005;140(3):376-391. doi: 10.1016/j.ajo.2005.03.038 - DOI - PubMed
    1. Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res. 2011;30(5):359-394. doi: 10.1016/j.preteyeres.2011.05.001 - DOI - PMC - PubMed
    1. Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol. 2011;152(5):820-3.e2. doi: 10.1016/j.ajo.2011.05.005 - DOI - PMC - PubMed
    1. Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology. 2009;116(10):1928-1936. doi: 10.1016/j.ophtha.2009.03.006 - DOI - PMC - PubMed
    1. Pick J, Nickels S, Saalmann F, Finger RP, Schuster AK. Incidence of retinal artery occlusion in Germany. Acta Ophthalmol. 2020;98(5):e656-e657. doi: 10.1111/aos.14369 - DOI - PubMed